JP2012518669A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518669A5
JP2012518669A5 JP2011551471A JP2011551471A JP2012518669A5 JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5 JP 2011551471 A JP2011551471 A JP 2011551471A JP 2011551471 A JP2011551471 A JP 2011551471A JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5
Authority
JP
Japan
Prior art keywords
use according
amino acids
surface active
natural
active protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551471A
Other languages
English (en)
Other versions
JP5832302B2 (ja
JP2012518669A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/052125 external-priority patent/WO2010097344A1/en
Publication of JP2012518669A publication Critical patent/JP2012518669A/ja
Publication of JP2012518669A5 publication Critical patent/JP2012518669A5/ja
Application granted granted Critical
Publication of JP5832302B2 publication Critical patent/JP5832302B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (2)

  1. 前記表面活性タンパク質が、未改質又はグリコシル化、アシル化又は架橋されていてよい、天然又は組換えハイドロフォビンから選択される1つ以上のタンパク質である、請求項1又は2に記載の使用。
  2. 前記表面活性タンパク質が、一般構造式(I)
    Figure 2012518669
    [式中、Xは20個の天然アミノ酸Phe、Leu、Ser、Tyr、Cys、Trp、Pro、His、Gln、Arg、Ile、Met、Thr、Asn、Lys、Val、Ala、Asp、Glu、Glyのいずれかであってよく、Xは、同一又は異なってよく、それぞれの場合においてXに隣接する指数は、アミノ酸の数を示し、Cは、システイン、アラニン、セリン、グリシン、メチオニン又はトレオニンであり、その際Cによって示されるアミノ酸(C1〜C8のうち少なくとも4つはシステインであり、かつ指数n及びmは、それぞれ互いに独立して、0〜500、有利には15〜300、さらに有利には15〜200の整数である]のポリペプチドから選択される1つ以上のタンパク質である、請求項1から3までのいずれか1項に記載の使用。
JP2011551471A 2009-02-26 2010-02-19 ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法 Expired - Fee Related JP5832302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153770.4 2009-02-26
EP09153770 2009-02-26
PCT/EP2010/052125 WO2010097344A1 (en) 2009-02-26 2010-02-19 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin

Publications (3)

Publication Number Publication Date
JP2012518669A JP2012518669A (ja) 2012-08-16
JP2012518669A5 true JP2012518669A5 (ja) 2014-07-31
JP5832302B2 JP5832302B2 (ja) 2015-12-16

Family

ID=40834317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551471A Expired - Fee Related JP5832302B2 (ja) 2009-02-26 2010-02-19 ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法

Country Status (8)

Country Link
US (1) US8758730B2 (ja)
EP (1) EP2400988B1 (ja)
JP (1) JP5832302B2 (ja)
KR (1) KR20110130440A (ja)
CN (1) CN102333546B (ja)
CA (1) CA2784516C (ja)
WO (1) WO2010097344A1 (ja)
ZA (1) ZA201203028B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113451A2 (en) * 2012-01-31 2013-08-08 Unilever Plc Personal care composition
EP2884975B1 (en) 2012-08-16 2019-07-31 Dusa Pharmaceuticals, Inc. Phototherapeutic agent for use in a method of treating onychomycosis
CN103980353A (zh) * 2014-05-21 2014-08-13 乔明强 一种疏水蛋白及其组成的药物制剂
RU2759134C2 (ru) * 2015-10-26 2021-11-09 Басф Се Продукты и способы для ухода за полостью рта, содержащие hlp
CN112198315B (zh) * 2020-09-11 2023-10-27 杭州奥泰生物技术股份有限公司 一种采集及检测指甲或趾甲样本中滥用药物的方法
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法
CN115701464B (zh) * 2021-08-02 2024-06-11 江苏金太阳纺织科技股份有限公司 超疏水整理剂及其制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3807915A1 (de) * 1988-03-10 1989-09-21 Wella Ag Mittel zur festigung der frisur und pflege des haares
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
WO1996041882A1 (en) 1995-06-12 1996-12-27 Proefstation Voor De Champignoncultuur Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
WO1997009960A1 (en) * 1995-09-14 1997-03-20 Sorenson Pharmaceutical, Inc. Composition and method for treating diseased nails
JP4227677B2 (ja) * 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6517863B1 (en) * 1999-01-20 2003-02-11 Usbiomaterials Corporation Compositions and methods for treating nails and adjacent tissues
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
FR2833490B1 (fr) 2001-12-14 2004-12-10 Oreal Utilisition cosmetique d'au moins une hydrophobine pour le traitement des matieres keratiniques et compositions mises en oeuvre
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
DE60303207T2 (de) 2002-06-21 2006-09-14 Applied Nanosystems B.V. Verfahren zur bindung einer verbindung an eine oberfläche
US7892788B2 (en) 2005-02-07 2011-02-22 Basf Se Hydrophobin fusion products, production and use thereof
WO2006103230A1 (de) 2005-03-30 2006-10-05 Basf Aktiengesellschaft Verwendung von hydrophobinen zur oberflächenbehandlung von gehärteten mineralischen baustoffen, naturstein, kunststein und keramiken
WO2006103638A2 (en) 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
WO2006103251A1 (de) 2005-04-01 2006-10-05 Basf Aktiengesellschaft Verwendung von proteinen als demulgatoren
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
DE102005033002A1 (de) 2005-07-14 2007-01-18 Basf Ag Wässrige Monomeremulsionen enthaltend Hydrophobin
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US20100166627A1 (en) 2007-05-24 2010-07-01 Basf Se Use of hydrophobins as additives in the crystallization of solids
RU2491096C9 (ru) * 2007-09-13 2014-02-10 Басф Се Применение гидрофобин-полипептидов в качестве усилителя пенетрации
JP2011527668A (ja) 2008-07-11 2011-11-04 ビーエーエスエフ ソシエタス・ヨーロピア 形態改質剤としての両親媒性タンパク質

Similar Documents

Publication Publication Date Title
JP2012518669A5 (ja)
HRP20190689T1 (hr) Muteini suznog lipokalina koji vežu il-4r alfa
JP2009268467A5 (ja)
JP2013515057A5 (ja)
JP2008521795A5 (ja)
RU2019119609A (ru) Пептиды, способные реактивировать мутанты р53
RU2009128979A (ru) Hla*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция
JP2018504419A5 (ja)
JP2018510622A5 (ja)
US10647742B2 (en) Method for synthesizing etelcalcetide
EA201170993A1 (ru) Удлиненные рекомбинантные полипептиды и содержащие их композиции
JP2004529067A5 (ja)
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2013527765A5 (ja)
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
EP2361930A3 (en) Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
JP2013543497A5 (ja)
JP2005516072A5 (ja)
JP2014506450A5 (ja)
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
ATE517118T1 (de) Bis-met-histone
RU2015103816A (ru) ПРОНИКАЮЩИЕ В КЛЕТКУ ПЕПТИДЫ, МИШЕНЬЮ КОТОРЫХ ЯВЛЯЕТСЯ eIF4E
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
TW201629085A (zh) 芋螺毒素(conotoxin)肽之修飾及用途